BPDCN

Latest News

Leukemia-Related Cutaneous Findings
Leukemia-Related Cutaneous Findings

January 30th 2023

This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.

Case Study Shows Liposomal Daunorubicin and Cytarabine (Vyxeos) as Promising Treatment for BPDCN
Case Study Shows Liposomal Daunorubicin and Cytarabine (Vyxeos) as Promising Treatment for BPDCN

December 19th 2022

HCVAD Chemotherapy Treatment Regimen Shows Promise for Blastic Plasmacytoid Dendritic Cell Neoplasm
HCVAD Chemotherapy Treatment Regimen Shows Promise for Blastic Plasmacytoid Dendritic Cell Neoplasm

December 19th 2022

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, Adolescents, and Young Adults
Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, Adolescents, and Young Adults

December 16th 2022

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium (NABC) Publishes Position Statement for BPDCN
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium (NABC) Publishes Position Statement for BPDCN

December 7th 2022

More News

© 2023 MJH Life Sciences

All rights reserved.